Liu T, Wu S, Fang W, Li H, et al. Identifying optimal first-line immune checkpoint inhibitors based regiments for advanced non-small cell lung cancer without oncogenic driver mutations: A systematic review and network meta-analysis. PLoS One 2023;18:e0283719.
PMID: 37071610